Ahmet Bilgehan Şahin

Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy

Ahmet Bilgehan Şahin, Erdem Çubukçu, Birol Ocak et al. · Scientific Reports · 2021 · 117 citations · Full text

Medicine, Immunology, Oncology +14

Risk Factors Affecting Graft and Patient Survivals After Transplantation From Deceased Donors in a Developing Country: A Single-Center Experience

Yavuz Ayar, Alparslan Ersoy, Gökhan Ocakoğlu et al. · Transplantation Proceedings · 2017 · 17 citations

Medicine, Hematology, Surgery +12

Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience

Aykut Bahçeci, Semra Paydaş, Naziye Ak et al. · Cancer Investigation · 2021 · 16 citations

Medicine, Oncology, Pharmacology +17

Clinical outcomes and survival in AA amyloidosis patients

Yavuz Ayar, Alparslan Ersoy, Mustafa Öksüz et al. · Revista Brasileira de Reumatologia (English Edition) · 2017 · 15 citations · Full text

Medicine, Clinical Sciences, Nephrology +17

Adrenocortical carcinoma: Single center experience

Pınar Şişman, Ahmet Bilgehan Şahin, Hande Peynirci et al. · Urology Research and Practice · 2017 · 12 citations · Full text

Medicine, Oncology, Surgery +17